• 1
    Panciera DL, Thomas CB, Eicker SW, et al. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980–1986). J Am Vet Med Assoc 1990;197:15041508.
  • 2
    Michiels L, Reusch CE, Boari A, et al. Treatment of 46 cats with porcine lente insulin: A prospective, multicentre study. J Feline Med Surg 2008;10:439451.
  • 3
    Nelson RW, Griffey SM, Feldman EC, et al. Transient clinical diabetes mellitus in cats: 10 cases (1989–1991). J Vet Intern Med 1999;13:2835.
  • 4
    Alt N, Kley S, Tschuor F, et al. Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus. Res Vet Sci 2007;83:331335.
  • 5
    Sieber-Ruckstuhl NS, Kley S, Tschuor F, et al. Remission of diabetes mellitus in cats with diabetic ketoacidosis. J Vet Intern Med 2008;22:13261332.
  • 6
    Roomp K, Rand J. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine. J Feline Med Surg 2009;11:668682.
  • 7
    Marshall RD, Rand JS, Morton JM. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins. J Feline Med Surg 2009;11:683691.
  • 8
    Zini E, Osto M, Franchini M, et al. Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia 2009;52:336346.
  • 9
    Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: Accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care 2008;31:539543.
  • 10
    Perfetti R, Rafizadeh CM, Liotta AS, et al. Age-dependent reduction in insulin secretion and insulin mRNA in isolated islets from rats. Am J Physiol 1995;269:E983E990.
  • 11
    Kolb H, Schneider B, Heinemann L, et al. Type 2 diabetes phenotype and progression is significantly different if diagnosed before versus after 65 years of age. J Diabetes Sci Technol 2008;2:8290.
  • 12
    Wilson DM. Progress in the treatment of childhood diabetes mellitus and obesity. J Pediatr Endocrinol Metab 2002;15:S745S749.
  • 13
    Achenbach P, Warncke K, Reiter J, et al. Type 1 diabetes risk assessment: Improvement by follow-up measurements in young islet autoantibody-positive relatives. Diabetologia 2006;49:29692976.
  • 14
    Hao M, Head WS, Gunawardana SC, et al. Direct effect of cholesterol on insulin secretion: A novel mechanism for pancreatic beta-cell dysfunction. Diabetes 2007;56:23282338.
  • 15
    Ishikawa M, Iwasaki Y, Yatoh S, et al. Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: A new model for lipotoxicity. J Lipid Res 2008;49:25242534.
  • 16
    Appleton DJ, Rand JS, Sunvold GD. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. J Feline Med Surg 2001;3:211228.
  • 17
    Reusch CE, Haberer B. Evaluation of fructosamine in dogs and cats with hypo- or hyperproteinaemia, azotaemia, hyperlipidaemia and hyperbilirubinaemia. Vet Rec 2001;148:370376.
  • 18
    Bennett N, Greco DS, Peterson ME, et al. Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus. J Feline Med Surg 2006;8:7384.
  • 19
    Buse JB, Caprio S, Cefalu WT, et al. Consesus statement: How do we define cure of diabetes? Diabetes Care 2009;32:21332135.